| Earnings Per Common Share The effect of dilutive securities on the weighted average common shares outstanding included in the calculation of earnings per diluted common share for the three and nine months ended September 30, 2026 and 2025 were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30 | | Nine Months Ended September 30 | | (number of shares in millions) | 2026 | | 2025 | | 2026 | | 2025 | | Weighted average common shares outstanding | 222.2 | | | 225.7 | | | 223.0 | | | 226.9 | | | Effect of dilutive securities: | | | | | | | | | Stock options | 0.1 | | | 0.1 | | | 0.1 | | | 0.1 | | | Other stock compensation plans | 0.9 | | | 0.7 | | | 0.7 | | | 0.7 | | | Potentially dilutive common shares | 1.0 | | | 0.8 | | | 0.8 | | | 0.8 | | | Adjusted weighted average common shares outstanding | 223.2 | | | 226.5 | | | 223.8 | | | 227.7 | | | | | | | | | | | Dividends per common share | $0.74 | | | $0.71 | | | $2.16 | | | $2.07 | | | | | | | | | | Antidilutive securities(a): | | | | | | | | | Stock options | 3.2 | | | 3.0 | | | 3.2 | | | 3.0 | |
(a)
|